左肾巨大血管周上皮样细胞肿瘤1例

马璐, 谢赣生, 殷虎明, 等. 左肾巨大血管周上皮样细胞肿瘤1例[J]. 临床泌尿外科杂志, 2022, 37(12): 966-968. doi: 10.13201/j.issn.1001-1420.2022.12.016
引用本文: 马璐, 谢赣生, 殷虎明, 等. 左肾巨大血管周上皮样细胞肿瘤1例[J]. 临床泌尿外科杂志, 2022, 37(12): 966-968. doi: 10.13201/j.issn.1001-1420.2022.12.016
MA Lu, XIE Gansheng, YIN Huming, et al. Giant perivascular epithelioid cell tumor of left kidney: a case report[J]. J Clin Urol, 2022, 37(12): 966-968. doi: 10.13201/j.issn.1001-1420.2022.12.016
Citation: MA Lu, XIE Gansheng, YIN Huming, et al. Giant perivascular epithelioid cell tumor of left kidney: a case report[J]. J Clin Urol, 2022, 37(12): 966-968. doi: 10.13201/j.issn.1001-1420.2022.12.016

左肾巨大血管周上皮样细胞肿瘤1例

详细信息

Giant perivascular epithelioid cell tumor of left kidney: a case report

More Information
  • 血管周上皮样细胞肿瘤(PEComa)是由上皮样细胞或梭形细胞形成的间充质肿瘤,它们对平滑肌和黑素细胞标志物均具有免疫反应性。PEComa包括血管平滑肌脂肪瘤、淋巴管肌瘤病、肺透明细胞“糖”瘤,以及一组罕见的、形态学和免疫表型相似的病变,起源于各种内脏和软组织部位,其特征是肌肉和黑色素生成标记物的共表达。PEComa通常最多出现在内脏(尤其是胃肠道和子宫)、腹膜后和腹盆腔部位,一个子集出现在躯体软组织和皮肤中。几乎所有PEComa都显示出对两者的免疫反应性黑色素细胞(HMB-45或Melan-A)且光滑肌肉(肌动蛋白或结蛋白)标记物。在泌尿生殖道中,PEComa可见于肾脏、膀胱、前列腺、睾丸和尿道。PEComa肿瘤多呈良性,以肾脏血管平滑肌脂肪瘤最为常见,肾脏恶性PEComa少见,现将苏州大学附属第一医院收治的1例报道如下。
  • 加载中
  • 图 1  平扫和增强CT

    图 2  HE染色和免疫组化染色

    图 3  患者术后复查平扫CT

  • [1]

    Valencia-Guerrero A, Pinto A, Anderson WJ, et al. PNL2: A useful adjunct biomarker to HMB45 in the diagnosis of uterine perivascular epithelioid cell tumor(PEComa)[J]. Int J Gynecol Pathol, 2020, 39(6): 529-536. doi: 10.1097/PGP.0000000000000653

    [2]

    Gulavita P, Fletcher C, Hirsch MS. PNL2: an adjunctive biomarker for renal angiomyolipomas and perivascular epithelioid cell tumours[J]. Histopathology, 2018, 72(3): 441-448. doi: 10.1111/his.13369

    [3]

    Chiang S, Vasudevaraja V, Serrano J, et al. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition[J]. Mod Pathol, 2022, 35(1): 117-127. doi: 10.1038/s41379-021-00922-7

    [4]

    Igaz P, Toth G, Nagy P, et al. Surprising genetic and pathological findings in a patient with giant bilateral periadrenal tumours: PEComas and mutations of PTCH1 in Gorlin-Goltz syndrome[J]. J Med Genet, 2022, 59(9): 916-919. doi: 10.1136/jmedgenet-2021-108082

    [5]

    Yang Y, Yu X, Lu B, et al. Perivascular epithelioid cell tumor(PEComa)of the kidney: an overview of its management and outcomes[J]. J Int Med Res, 2020, 48(10): 300060520961223.

    [6]

    Wagner AJ, Ravi V, Riedel RF, et al. Nab-Sirolimus for patients with malignant perivascular epithelioid cell tumors[J]. J Clin Oncol, 2021, 39(33): 3660-3670. doi: 10.1200/JCO.21.01728

    [7]

    Çalişkan S, Gümrükçü G, Özsoy E, et al. Renal angiomyolipoma[J]. Rev Assoc Med Bras(1992), 2019, 65(7): 977-981. doi: 10.1590/1806-9282.65.7.977

    [8]

    Koenig KL, Sahasrabudhe KD, Sigmund AM, et al. AML with myelodysplasia-related changes: development, challenges, and treatment advances[J]. Genes(Basel), 2020, 11(8): 111.

    [9]

    Caliò A, Brunelli M, Marletta S, et al. Epithelioid angiomyolipoma: a pathological entity discovered in Verona with the endorsement of Doctor Rosai[J]. Pathologica, 2021, 113(5): 307-315. doi: 10.32074/1591-951X-335

    [10]

    Liapi A, Mathevet P, Herrera FG, et al. VEGFR inhibitors for uterine metastatic perivascular epithelioid tumors(PEComa)resistant to mtor inhibitors. a case report and review of literature[J]. Front Oncol, 2021, 11: 641376. doi: 10.3389/fonc.2021.641376

    [11]

    王东艳, 张强, 杨志刚. 肾血管周上皮样细胞瘤1例[J]. 临床泌尿外科杂志, 2020, 35(6): 497-498. https://www.cnki.com.cn/Article/CJFDTOTAL-LCMW202006019.htm

    [12]

    柳赫, 朱永锋, 张春霆. 肾上腺恶性血管周上皮样细胞肿瘤1例[J]. 临床泌尿外科杂志, 2020, 35(12): 1021-1022. https://www.cnki.com.cn/Article/CJFDTOTAL-LCMW202012020.htm

  • 加载中

(3)

计量
  • 文章访问数:  940
  • PDF下载数:  503
  • 施引文献:  0
出版历程
收稿日期:  2021-10-09
刊出日期:  2022-12-06

目录